PSCA expression in invasive micropapillary carcinoma of breast

Chinese Journal of Pathology

Volumn 40, Issue 6, 2011, Pages 382-386

  Hao, Jin Yan ^a   Yang, Yi Ling ^a   Li, Shuai ^a   Qian, Xiao Long ^a   Liu, Fang Fang ^a   Fu, Li ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Breast neoplasms; Carcinoma; Neoplasm metastasis; Papillary; Prostate stem cell antigen

Indexed keywords

GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; MESSENGER RNA; PSCA PROTEIN, HUMAN; TUMOR ANTIGEN; TUMOR PROTEIN;

ARTICLE; BREAST TUMOR; CANCER INVASION; CANCER STAGING; FEMALE; GENETICS; HUMAN; LYMPH NODE METASTASIS; METABOLISM; PAGET NIPPLE DISEASE; PAPILLARY CARCINOMA; PATHOLOGY;

ANTIGENS, NEOPLASM; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, PAPILLARY; FEMALE; GPI-LINKED PROTEINS; HUMANS; LYMPHATIC METASTASIS; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; NEOPLASM STAGING; RNA, MESSENGER;

EID: 79960507378     PISSN: 05295807     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0529-5807.2011.06.006     Document Type: Article

References (23)

1. Gu Z, Thomas G, Yamashiro J, et al. Prostate stem cell antigen ( PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancer. Oncogene, 2000,19(10):1288-1296. (Pubitemid 30160621)
2. Liu WK, Jiang XY, Zhang ZX. Expression of PSCA, PIWIL1 , and TBX2 in endometrial adenocarcinoma. Onkologie, 2010, 33 (5): 241-245.
3. Tavassoeli FA, Devilee P. World Health Organization classification of tumours. Pathology and genetics of tumours of the breast and female genital organs. Lyon: IARC Press, 2003.
4. Hanley KZ, Birdsong GG, Cohen C, et al. Immunohistochemical detection of estrogen receptor,progesterone receptor, and human epidermal growth factor receptor 2 expression in breast carcinomas: comparison on cell block, needle-core, and tissue block preparations. Cancer, 2009, 117(4): 279-288.
5. Sauter G, Lee J, Bartlett JM, el al. Guidelines for human epidermal growth factor receptor 2 testing: biologic and melhodologic considerations. J Clin Oncol, 2009, 27(8): 1323-1333.
6. Reiter RE, Gu Z, Watabe T, et al. Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer. Proc Natl Acad Sci U S A, 1998, 95(4) : 1735-1740. (Pubitemid 28103463)
7. Zhigang Z, Wenlu S. Flutamide reduced prostate cancer development and prostate stem cell antigen mRNA expression in high grade prostatic intraepithelial neoplasia. Int J Cancer,2008, 122(4): 864-870.
8. Ross S, Spencer SD, Holcomb I, et al. Prostate stem cell antigen as therapy target: tissue expression and in vivo efficacy of an immunoconjugate. Cancer Res, 2002,62(9) : 2546-2553. (Pubitemid 34462733)
9. Watabe T, Lin M, Ide H, et al. Growth, regeneration, and tumorigenesis of the prostate activates the PSCA promoter. Proc Natl Acad Sci USA, 2002, 99(1): 401-406. (Pubitemid 34060373)
10. Bahrenberg G, Brauers A, Joost HG, et al. PSCA expression is regulated by phorbol ester and cell adhesion in the bladder carcinoma cell line RT112. Cancer Lett, 2001, 168( 1) : 37-43. (Pubitemid 32463910)
11. Witz IP. Differential expression of genes by tumor cells of a low or a high malignancy phenotype: the case of murine and human Ly-6 proteins. J Cell Biochem Suppl, 2000, 34: 61-66. (Pubitemid 30176734)
12. Eshel R, Zanin A, Sagi-Assif 0, et al. The GPI-linked Ly-6 antigen E48 regulates expression levels of the FX enzyme and of E-selectin ligands on head and neck squamous carcinoma cells. J Biol Chem, 2000, 275( 17) : 12833-12840. (Pubitemid 30241438)
13. Rege TA, Hagood JS. Thy-1, a versatile modulator of signaling affecting cellular adhesion, proliferation, survival, and cytokine/growth factor responses. Biochim Biophys Acta, 2006, 1763 (10): 991-999. (Pubitemid 44466122)
14. Thomas PM, Samelson LE. The glycophosphatidylinositol-anchored Thy-1 molecule interacts with the p60fyn protein tyrosine kinase in T cells. J Biol Chem, 1992, 267( 17) : 12317-12322.
15. Argani P, Rosty C, Reiter RE, et al. Discovery of new markers of cancer through serial analysis of gene expression: prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma. Cancer Res, 2001, 61(11): 4320-4324. (Pubitemid 32685751)
16. Elsamman E, Fukumori T, Kasai T, et al. Prostate stem cell antigen predicts tumour recurrence in superficial transitional cell carcinoma of the urinary bladder. BJU Int, 2006, 97(6): 1202-1207. (Pubitemid 43907322)
17. Wu C, Wang G, Yang M, et al. Two genetic variants in prostate stem cell antigen and gastric cancer susceptibility in a Chinese population. Mol Carcinog, 2009, 48( 12) :1131-1138.
18. Feng HC, Tsao SW, Ngan HY, et al. Overexpression of prostate stem cell antigen is associated with gestational trophoblastic neoplasia. Histopathology, 2008, 52(2): 167-174.
19. Elsamman EM, Fukumori T, Tanimoto S, et al. The expression of prostate stem cell antigen in human clear cell renal cell carcinoma: a quantitative reverse transcriptase-polymerase chain reaction analysis. BJU Int, 2006, 98(3) : 668-673. (Pubitemid 44185896)
20. Kawaguchi T, Sho M, Tojo T, et al. Clinical significance of prostate stem cell antigen expression in non-small cell lung cancer. Jpn J Clin Oncol, 2010, 40(4) : 319-326.
21. Liu WK, Jiang XY, Zhang ZX, et al. Expression of PSCA, PIWIL1 and TBX2 and its correlation with HPV16 infection in formalin-fixed, paraffin-embedded cervical squamous cell carcinoma specimens. Arch Virol, 2010, 155(5) : 657-663.
22. Marchib C, Iravani M, Natrajan R, et al. Genomic and immunophenotypical characterization of pure micropapillary carcinomas of the breast. J Pathol, 2008, 215(4): 398410.
23. Marchib C, Iravani M, Natrajan R, et al. Mixed micropapillary-ductal carcinomas of the breast: a genomic and immunohistochemical analysis of morphologically distinct components. J Pathol, 2009, 218(3): 301-315.